Clinical Trial Update: Multicenter Trial of ESK981 in Patients With Select Solid Tumors [Phase 2]

View source ↗

Summary

This document reports a Phase 2 multicenter clinical trial of ESK981 in select solid tumors. The study is currently recruiting across specified pancreatic and g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosquamous Carcinoma
• Gastrointestinal Neuroendocrine Carcinoma
• Gastrointestinal Neuroendocrine Tumor
• Pancreatic Adenocarcinoma
• Pancreatic Neuroendocrine Carcinoma
• Pancreatic Neuroendocrine Tumor
• Prostate Neuroendocrine Carcinoma

Drugs mentioned

• ESK981

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Pancreatic Adenocarcinoma, Adenosquamous Carcinoma | Phase 2 | Status: RECRUITING